Prevalence and Risk Factors for the Carriage of Bacteria and Clostridioid in Elderly Dependent Persons
PREMS
1 other identifier
observational
492
1 country
1
Brief Summary
Brief summary : Very few studies have evaluated the prevalence of multi-drug resistant (MDR), highly resistant emerging bacteria and Clostridioides difficile toxinogenic (CDt) in residents and in healthcare workers (HCW) in nursing home (NH). Most of study were conducted in acute care services and were limited to specific bacterial species. Hypothesis : The carriage of MDR bacteria in resident may be a risk factor for an outbreak in NH or in healthcare facility. Primary outcome: The objective of this study is to estimate the prevalence for carriage of MDR bacteria and CDt in residents in NH. Secondary outcomes:
- Estimate the prevalence for carriage of MDR bacteria and CDt toxigenic in HCW in NH.
- Identify the risk factors for carriage of MDR bacteria and CDt in residents in nursing home
- Identify the risk factors for carriage of MDR bacteria and CDt in healthcare workers in NH
- Evaluate the presence of cross-transmission of MDR bacteria and CDt in one or several NH
- Evaluate the association between the presence of cross-transmission of MDR bacteria and CDt in a NH and the management of infection control
- Establishment a collection of stool samples
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedStudy Start
First participant enrolled
May 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedMay 28, 2025
May 1, 2025
2.4 years
October 1, 2020
May 26, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Presence or absence of multi-drug resistant bacteria in residents' feces.
prevalence of carriage of multi-drug resistant bacteria
at inclusion (J0)
Presence or absence of Highly Resistant and Emerging Bacteria in residents' feces.
prevalence of carriage of Highly Resistant and Emerging Bacteria
at inclusion (J0)
Presence or absence of Clostridioids difficult toxinogenic in residents' feces.
prevalence of carriage of Clostridioids difficult toxinogenic
at inclusion (J0)
Study Arms (2)
1/elderly dependent persons
2/healthcare workers (HCW)
Interventions
Feces sampling at inclusion (J0)
Eligibility Criteria
The target population of the study is all elderly residents of nursing home and their caregivers. The source population of the study corresponds to the residents of the 61 nursing home in the Gard region, and their caregivers.
You may qualify if:
- Resident :
- The resident must be a member or beneficiary of a health insurance. The resident is in permanent accommodation whose the date of admission is at least 1 month earlier on the day of collection.
- healthcare workers : The healthcare workers must be a member or beneficiary of a health insurance. The healthcare workers begin to work in nursing at least 1 month earlier on the day of collection.
You may not qualify if:
- Resident :
- The resident refuses to participate.
- o healthcare workers : The healthcare workers refuses to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nîmes, Hôpital Universitaire Carémeau
Nîmes, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2020
First Posted
October 8, 2020
Study Start
May 25, 2022
Primary Completion
September 30, 2024
Study Completion
September 30, 2024
Last Updated
May 28, 2025
Record last verified: 2025-05